Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity
Clinical trial NCT02870231 · COMPLETED
Trial details
- NCT number
- NCT02870231
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-18
- Primary completion
- 2017-09-03
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.